NASA Center: Johnson Space Center
Public Release Year: 1999
Reference Number: JSC-SO-138
Category: Health And Medicine
Origin: Development of Non-centrifugation Device for The Collection and Real-time Analysis of Blood and Other Bodily Fluids on Space Missions
The method that is used for the collection, storage and real-time analysis of blood and other bodily fluids has been licensed to DBCD, Inc. by NASA. The result of this patent licensing agreement has been the development of a commercial product that can provide serum or plasma from whole blood volumes of 20 microliters to 4 milliliters. The device has a fibrous filter with a pore size of less than about 3 microns, and is coated with a mixture of mannitol and plasma fraction protein. The coating causes the cellular fraction to be trapped by the small pores, leaving the cellular fraction intact on the fibrous filter while the acellular fraction passes through the filter for collection in unaltered form from the serum sample collection chamber. The method used by this product is useful to NASA for blood analysis on manned space missions.
Page Number in Published book: 46